Article Details

Affimed Presents Updated Clinical Data from Phase 1/2 Study - GlobeNewswire

Retrieved on: 2022-04-10 16:29:35

Tags for this article:

Click the tags to see associated articles and topics

Affimed Presents Updated Clinical Data from Phase 1/2 Study - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2022/04/10/2419614/0/en/Affimed-Presents-Updated-Clinical-Data-from-Phase-1-2-Study-of-AFM13-Precomplexed-with-Cord-Blood-Derived-NK-Cells-at-AACR-Annual-Meeting.html

Excerpt

100% objective response rate and improvement in the rate of complete ... immune effector cell-associated neurotoxicity or graft versus host ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up